We are D-histidine CAS:351-50-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
| Solubility in water | Colorless & clear (c=3) |
| Specific rotation [α]D20 | -11.8°～-12.8°(c= 11, 6M-HCl) |
| Loss on drying | Not more than 0.3% |
| Residue on ignition (as sulfate) | Not more than 0.1% |
| Chloride (Cl) | Not more than 0.02% |
| Sulfate (SO4) | Not more than 0.03% |
| Heavy metals (as Pb) | Not more than 10ppm |
| Iron (Fe) | Not more than 10ppm |
| Ammonium (NH4) | Not more than 0.02% |
| Arsenic (As2O3) | Not more than 1ppm |
| Other amino acids | Not detected by T.L.C.(The spotted amount, 20μg) |
| Assay | 98.5%～101.0% |
| L-Isomer | Not more than 0.5% |
Related News: Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.Trichloro(1H,1H,2H,2H-tridecafluoro-n-octyl)silane Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.3-(Methacryloyloxy)Propyltris(Trimethylsiloxy)Silane CAS:17096-07-0 Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.Silicato de etilo 32 CAS:68412-37-3 Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.
| Product Name | |
|---|---|
| 3-ACETYL-2,5-DIMETHYLFURAN Cas:10599-70-9 | View Details |
| 2,4,6-Tri-tert-butylphenol Cas:732-26-3 | View Details |
| Linocaine Hydrochloride Cas:6108-05-0 | View Details |